北京市某三级医院上消化道出血住院患者病因特征及治疗费用分析

doi:10.12183/j.scjpm.2022.0808

摘要/Abstract

摘要： 目的探讨上消化道出血（UGIB）患者的病因特征,分析所承担的治疗费用及其影响因素。方法从平谷区某医院信息管理系统中导出2016年10月至2021年9月UGIB住院患者基线资料、检查结果、治疗及住院时间等信息。并从医院收费系统调取患者住院费用、手术费、输血费、西药费、中成药费等相关治疗费用信息。采用描述性及非参数分析临床资料及治疗费用,采用多重线性回归分析治疗费用的相关因素。结果共纳入1 022例UGIB住院患者,男性732例（71.62%）,女性290例（28.38%）,男女比例为2.52∶1;18~44岁209例,45~59岁244例,60岁及以上569例。不同性别的疾病年龄分布差异有统计学意义（P<0.01）。1 022例UGIB患者住院时间为14（10,17）d,治疗费用：检查费为2 755.0（1 988.0,4 575.3）元,手术费为1 870.0（1 380.0,2 603.0）元,输血费为1 546.0（0,2 773.3）元,西药费为9 746.5（8 765.5,11 527.3）元,中成药费为212.0（168.8,255.0）元,总费用为16 007.5（12 581.3,19 916.5）元。多重线性回归分析结果显示,年龄（β’=0.574）、合并高血压（β’=0.054）、合并冠心病（β’=0.064）、是否输血（β’=0.257）、是否胃癌（β’=0.047）以及住院时间（β’=0.230）为影响治疗费用的影响因素。结论 UGIB男性患者多于女性,不同年龄组病因存有差异,老年患者治疗费用较高,合并高血压、冠心病、输血、住院时间较长亦为高治疗费用的关键影响因素。

关键词: 上消化道出血, 病因特征, 治疗费用, 影响因素

Abstract: Objective To investigate the etiological characteristics of patients with upper gastrointestinal bleeding （UGIB） and to analyze the treatment costs and its influencing factors. Methods From October 2016 to September 2021, the baseline data, examination results, treatment, and hospitalization time of UGIB inpatients were derived from the hospital information management system of a hospital in Pinggu District. And from the hospital charging system, the relevant treatment costs information such as hospitalization expenses, operation fees, blood transfusion fees, western medicine fees, and Chinese patent medicine fees was retrieved. Descriptive and nonparametric analyses were used to analyze clinical data and treatment costs, and multiple linear regression was used to analyze the related factors of treatment costs. Results A total of 1 022 UGIB inpatients were included, including 732 males （71.62%） and 290 females （28.38%）, with a male-female ratio of 2.52∶1; 209 patients aged 18-44 years old, 244 patients aged 45-59 years old, 569 patients aged 60 and years old. There was a statistically significant difference in the age distribution of disease among different genders （P<0.01）. The hospitalization time of 1 022 UGIB patients was 14 （10, 17） days, and the treatment costs： the examination fee was 2 755.0 （1 988.0, 4 575.3） yuan, the operation fee was 1 870.0 （1 380.0, 2 603.0） yuan, the blood transfusion fee was 1 546.0 （0, 2 773.3） yuan, the western medicine fee was 9 746.5 （8 765.5, 11 527.3） yuan, the Chinese patent medicine fee was 212.0 （168.8, 255.0） yuan, and the total cost was 16 007.5 （12 581.3, 19 916.5） yuan. The results of multiple linear regression analysis showed that age （β’=0.574）, hypertension （β’=0.054）, coronary heart disease （β’=0.064）, blood transfusion （β’=0.257）, gastric cancer （β’=0.047）, and the length of hospitalization time （β’=0.230） were the influencing factors of treatment costs. Conclusion Male patients with UGIB are more than female patients, and there are differences in etiology in different age groups. Elderly patients have higher treatment costs, combined with hypertension, coronary heart disease, blood transfusion, and long hospitalization time are also risk factors for high treatment costs.

Key words: Upper gastrointestinal bleeding, Etiological characteristics, Treatment cost, Influencing factor

中图分类号:

R573

庞敏, 卢丽娜, 匡哲, 郭慧丽. 北京市某三级医院上消化道出血住院患者病因特征及治疗费用分析[J]. 华南预防医学, 2022, 48(7): 808-812.

PANG Min, LU Li-na, KUANG Zhe, GUO Hui-li. Etiological characteristics and treatment costs of inpatients with upper gastrointestinal bleeding in an A tertiary hospital in Beijing[J]. South China Journal of Preventive Medicine, 2022, 48(7): 808-812.

参考文献

[1] Matsuhashi T, Fukuda S, Mikami T, et al.Effects of anti-thrombotic drugs on all-cause mortality after upper gastrointestinal bleeding in Japan: A multicenter study with 2205 cases[J]. Dig Endosc,2022,34(1):113-122.
[2] 刘霜,张小明,杨美霞,等. 急性上消化道出血患者既往出血次数与90 d全因死亡和再出血的关系:一项真实世界研究[J]. 中华急诊医学杂志,2021,30(5):593-601.
[3] Sung JJY, Laine L, Kuipers EJ, et al.Towards personalised management for non-variceal upper gastrointestinal bleeding[J]. Gut,2021,70(5):818-824.
[4] Lye TJY, Chang JHE, Lim CH.Authors’reply: Systematic review and meta-analysis of prophylactic transarterial embolization for high-risk bleeding peptic ulcer disease[J]. J Vasc Interv Radiol, 2021,32(9):1390-1391.
[5] 朱健康,艾克帕尔·艾肯,王义霞,等. 喀什地区维吾尔族与汉族人群上消化道出血的流行病学和病因演变[J]. 中华消化杂志,2020,40(12):874-877.
[6] 李静蕾,程平,盛卫勇,等. 急性上消化道出血止血新技术的诊疗进展[J]. 世界华人消化杂志,2021,29(18):1035-1042.
[7] 魏娜,郑智源,郑斌,等. 生长抑素及其类似物联合质子泵抑制剂应用于急性非静脉曲张性上消化道出血的循证分析[J]. 中国现代应用药学,2019,36(16):2062-2070.
[8] 中国医师协会急诊医师分会. 急性上消化道出血急诊诊治流程专家共识[J]. 中国急救医学,2015,35(10):865-873.
[9] 陈世华,陈维顺,屈伟明. 奥美拉唑联合复方倍他米松治疗上消化道出血合并痛风急性发作[J]. 中华生物医学工程杂志,2017,23(3):235-238.
[10] Chue KM, Boey JY, Ng BSM, et al.Admission discipline and timing of admission may influence outcomes for gastrointestinal bleeding patients[J]. ANZ J Surg,2021,91(9):1832-1840.
[11] Fischbach W, Klassert C, Schilling D, et al.Acute gastrointestinal bleeding: Results from the prospective German electronic registry of nearly 11?000 endoscopies (ALGK GI-bleeding registry)[J].Z Gastroenterol, 2021,59(5):446-453.
[12] 杨旺明,叶泽兵,饶先伟,等. 不同年龄段急性上消化道出血患者的病因及临床特征分析[J]. 海南医学,2014,25(13):1975-1976.
[13] 陈欣,戴军,余珊. 内镜下套扎联合药物治疗对肝硬化上消化道出血患者hs-CRP水平、肝功能的影响[J]. 分子诊断与治疗杂志,2021,13(1):144-147.
[14] 黄玉林. 消化性溃疡患者非甾体类抗炎药服用史和幽门螺杆菌感染的协同致病性[J]. 中国老年学杂志,2018,38(2):389-390.
[15] 王裕宣. 上消化道出血严重程度与幽门螺旋杆菌感染及胃癌前疾病的相关性研究[J]. 实用癌症杂志,2016,31(10):1648-1651.
[16] 王晓燕,刘云云,王玉欣,等. 内镜黏膜下剥离术治疗早期胃癌及癌前病变效果及继发出血独立危险因素探讨[J]. 临床消化病杂志,2020,32(1):21-24.
[17] 夏迪,张铭光. 成都市某医院上消化道出血住院患者病例特征及治疗费用分析[J]. 华南预防医学,2020,46(5):498-501,505.
[18] 李兴雨,马一涵,史旋,等. 空腹血糖对新发上消化道出血发病风险的影响:前瞻性队列研究[J]. 中国全科医学,2021,24(9):1051-1056,1065.
[19] 奚黎婷,朱锦舟,虞晨燕,等. 急性非静脉曲张性上消化道出血患者再出血预测模型和新型评分系统的构建[J]. 上海交通大学学报(医学版),2021,41(11):1491-1497.